INTELLIGENT BIO SOLUTIONS INC. Grants Receivable
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Grants Receivable of $2.60 million as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Notes › Nontrade Receivables
us-gaap:GrantsReceivable · last filed 2023-05-11
- 2022-12-31: Grants Receivable $2.60M.
- 2022-06-30: Grants Receivable $2.10M; Grants Receivable as first filed $2.60M.
- 2022-03-31: Grants Receivable $2.80M.
- 2021-12-31: Grants Receivable $2.80M.
| Period end | Grants Receivable | Grants Receivable as first filed |
|---|---|---|
| 2022-12-31 | $2.60M 10-Q · filed 2023-02-14 | |
| 2022-06-30 | $2.10M 10-Q · filed 2023-05-11 | $2.60M 10-K · filed 2022-09-22 |
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.80M 10-Q · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |